Looking at kidney problems in people with Wilson disease
Describes kidney involvement through full kidney checks in people with Wilson disease.
Key facts
- Who runs it
- Fondation Ophtalmologique Adolphe de Rothschild
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Description of Renal Involvement in Wilson's Disease
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 22 Jul 2026
- Expected to end
- Jul 2029
- Type of study
- Observational
- Treatments tested
- full renal workup
- Record updated
- 1 October 2026
Who can take part
The trial is looking for people with Wilson's disease, to check how the disease affects their kidneys. Each person gets a full kidney workup.
- Age
- 7 years and older
- Sex
- All sexes
- Disease stage
- Diagnosed Wilson's disease, with a Leipzig score ≥ 4 (a score used to confirm the diagnosis).
- Earlier treatment
- People who have had an organ transplant cannot join.
- Main reasons for not taking part
- Had an organ transplant
- Known kidney disease not caused by Wilson's disease
- Pregnant or breastfeeding women
Show the full registry criteria (5)Hide the full registry criteria
Who can take part
- Patient aged 7 years and older
- Diagnosed with Wilson's disease, with a Leipzig score ≥ 4
Who cannot take part
- Patient who has undergone organ transplantation
- Known renal comorbidity unrelated to Wilson's disease
- Pregnant or breastfeeding woman
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Wilson disease
This trial is currently available in France.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Wilson's disease (WD) is a rare genetic disorder that leads to copper accumulation in various tissues, including the liver, nervous system, heart, and kidneys. Renal involvement in WD has been poorly studied, and systematic screening is not currently recommended.
Read full original descriptionShow less
Indirect renal complications are the most common, such as hepatorenal and cardiorenal syndromes, as well as severe complications like hemolysis or rhabdomyolysis. However, literature suggests that copper may exert a direct toxic effect on renal tubular cells, leading to both proximal and distal tubular dysfunction. These may manifest through often subtle signs, such as aminoaciduria, glycosuria, hypouricemia, and low-molecular-weight proteinuria. Electrolyte imbalances of varying severity may also occur, including hypokalemia, which can cause muscle cramps and cardiac arrhythmias, as well as acid-base disorders (proximal or distal renal tubular acidosis), and/or phosphate-calcium metabolism abnormalities (phosphate diabetes and hypercalciuria). These latter issues may lead to complications such as urinary stones, nephrocalcinosis, and even fracture-related osteoporosis.
In addition, long-term treatment with D-penicillamine (DPA), a common therapy for WD, can cause renal damage in 10-20% of cases, mainly affecting the glomeruli. This includes membranous nephropathy, severe proliferative glomerulonephritis, or nephrotic syndrome with minimal change disease.
Without appropriate monitoring and preventive care, both direct and indirect renal complications can lead to acute or chronic kidney failure. It is likely that the prevalence and systemic impact of renal involvement in WD are currently underestimated.
The group in the trial
- Wilson disease patients
Patients followed for wilson disease
Treatment: full renal workup
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Description of Renal Involvement in Wilson's Disease
- Plain-language title
- Looking at kidney problems in people with Wilson diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07075393, who can take part
- Record updated
- 1 October 2026